The scrip zoomed to a high of Rs 1,430 and finally ended at Rs 1,391, up 6% from the previous close. The counter clocked volumes of 131,422 shares as compared to 25,274 shares traded on the BSE.
___________________________________________________
(Updated at 1448hrs)
The shares of Sun Pharma are quoting 6.78% up at Rs 1399.90 . They opened at Rs 1320.00, touched a high of Rs 1430 and a low of Rs 1298.95 during the day.
Sun Pharmaceutical Industries recently received the clearance of US Anti-Trust authorities for its open offer to acquire additional shares of Israeli-drug maker Taro Pharmaceutical. The company had filed an application for review of its open offer, launched last year, for buying additional stake in Israel-based Taro Pharmaceuticals by the US authorities on Aug. 28, 2009.
Besides, Sun Pharma aims to file 30 applications in the US for manufacturing and marketing its generic products.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app